McDermott Wendy

McDermott Wendy is listed in filings as SVP at Lexicon Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 3, 2026, including 12 public disclosures. Recent filings connect the profile to Lexicon Pharmaceuticals, Inc. (LXRX). The current snapshot covers public activity from Feb 18, 2025 to Mar 3, 2026. Reported amounts are shown as $100.1K to $20.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.